MarketCap
Facebook
X
TelegramAnnual report 2022
added 12-21-2024
Genetron Holdings Limited Operating Cash Flow 2011-2026 | GTH
Annual Operating Cash Flow Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -524 M | -301 M | -197 M | -201 M | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -197 M | -524 M | -306 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 15.96 | 5.63 % | $ 483 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.76 | 1.09 % | $ 177 M |  China |
 |
Castle Biosciences
CSTL
|
64.3 M | $ 19.83 | 3.07 % | $ 575 M | USA |
 |
Agilent Technologies
A
|
1.48 B | $ 115.62 | -2.55 % | $ 35.1 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 21.82 | 1.77 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
390 M | $ 93.06 | 2.26 % | $ 6.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 424.0 | -1.1 % | $ 12.2 B | USA |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 2.53 | 31.09 % | $ 3.37 M | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.29 | 4.89 % | $ 397 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.96 | -1.21 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 18.75 | 0.11 % | $ 420 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Natera
NTRA
|
-432 M | $ 194.24 | -11.64 % | $ 19.1 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 177.62 | -2.23 % | $ 8.8 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
-74.9 M | $ 5.98 | -0.17 % | $ 534 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 95.7 | 3.73 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 5.03 | -6.16 % | $ 210 M | USA |
 |
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.95 | - | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 124.49 | -0.41 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
837 M | $ 141.88 | 2.29 % | $ 22.6 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.95 | -2.5 % | $ 8.63 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.61 | 2.52 % | $ 219 M | Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 56.85 | -2.89 % | $ 3.4 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.15 | -2.05 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 465.0 | -1.99 % | $ 175 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 254.12 | -1.52 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 131.06 | 0.27 % | $ 6.13 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
653 M | $ 355.13 | 1.32 % | $ 21.1 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.05 | -2.16 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 187.39 | -1.82 % | $ 20.8 B | USA |